HIRSCHMAN ORIN 13D and 13G filings for Coya Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 08:35 am Purchase | 2024-12-31 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 1,333,919 8.000% | 169,547 (+14.56%) | Filing |
| 2024-02-07 6:55 pm Purchase | 2023-12-31 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 1,164,372 8.100% | 471,977 (+68.17%) | Filing |
| 2023-01-05 08:30 am Purchase | 2022-12-29 | 13G | Coya Therapeutics, Inc. COYA | HIRSCHMAN ORIN | 692,395 7.200% | 692,395 (New Position) | Filing |